Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study
2019
PURPOSEOff-label use of
vemurafenib(VMF) to treat BRAFV600E mutation–positive, refractory, childhood
Langerhans cell histiocytosis(LCH) was evaluated.PATIENTS AND METHODSFifty-four patients from ...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
32
References
52
Citations
NaN
KQI